With regard to the government’s commitment to provide free menstrual products in federally regulated workplaces, since January 1, 2019: (a) how many consultations has the government held on this policy; (b) how many stakeholders has the government consulted with on this policy; (c) what are the details of the consultations, including, for each consultation, the (i) names of organizations consulted, (ii) date, (iii) outcome, recommendation, or feedback; (d) what is the total cost of all consultations which have occurred to date; (e) what is the breakdown of (d) by date and line item; (f) have any outside consultants or service providers been involved in the development of this policy and any related consultations, and, if so, what are the details of each consultant or service provider's involvement, including the (i) name of the individual or firm, (ii) contract value, (iii) date of the contract, (iv) description of the goods or services provided; (g) what are all specific concerns that have been raised to date in the consultations; (h) how many government employees or full-time equivalents have worked on the consultations; (i) what are the travel costs associated with the consultations incurred to date (i) in total, (ii) broken down by year and type of expense; (j) what costs associated with the development of the government report “What We Heard: Proposal on the Provision of Menstrual Products in Federally Regulated Workplaces” have been incurred to date, (i) in total, (ii) broken down by type of expense; and (k) what is the current status of this policy proposal?
In the House of Commons on May 31st, 2023. See this statement in context.